Related Experiment Video

Updated: Jun 6, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells

Amandine Chaix1, Sophie Lopez, Edwige Voisset

  • 1INSERM, U891, Centre de Recherche en Cancérologie de Marseille, France.

The Journal of Biological Chemistry
|December 8, 2010
PubMed

Insights

Mutations in KIT signaling activate STAT proteins in mastocytosis. While KIT directly phosphorylates STATs, SRC kinases and JAKs are crucial for their activation within cells, with only STAT5 showing transcriptional activity.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • Mastocytosis is characterized by mutations in the c-kit gene, predominantly at amino acid 816 (KIT-Asp816).
  • KIT signaling pathways, particularly STAT3 and STAT5, are vital for neoplastic mast cell proliferation.

Purpose of the Study:

  • To elucidate the mechanisms of STAT protein activation downstream of the KIT-Asp816 mutant.
  • To investigate the roles of various STAT kinases in neoplastic mast cell lines (P815 and HMC-1).

Main Methods:

  • Analysis of STAT1, STAT3, and STAT5 activation in P815 and HMC-1 cell lines.
  • In vitro phosphorylation assays using the KIT-Asp816 mutant.
  • Pharmacological inhibition of SRC family kinases, JAKs, and serine/threonine kinases.
  • Assessment of STAT protein nuclear localization and phosphorylation status.
  • Evaluation of STAT transcriptional activity.

Main Results:

  • STAT1, STAT3, and STAT5 are activated and phosphorylated on serine residues in the nucleus downstream of KIT-Asp816.
  • KIT-Asp816 can directly phosphorylate STATs on tyrosine residues in vitro.
  • SRC family kinases and JAKs differentially contribute to STAT tyrosine phosphorylation in cells.
  • Specific serine/threonine kinases were implicated or excluded in STAT serine phosphorylation.
  • Only STAT5 demonstrated transcriptional activity in the studied mast cell lines.

Conclusions:

  • STAT protein activation downstream of KIT-Asp816 involves both direct and indirect mechanisms.
  • SRC kinases and JAKs play distinct roles in STAT tyrosine phosphorylation.
  • STAT5 is the primary transcriptionally active STAT protein in these neoplastic mast cells.
  • The function of STAT1 and STAT3 in this context may be independent of their transcriptional activity.

More Related Videos

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...